186 related articles for article (PubMed ID: 38505602)
1. FSH induces EMT in ovarian cancer via ALKBH5-regulated Snail m6A demethylation.
Xu X; Zhuang X; Yu H; Li P; Li X; Lin H; Teoh JP; Chen Y; Yang Y; Cheng Y; Chen W; Fu X
Theranostics; 2024; 14(5):2151-2166. PubMed ID: 38505602
[No Abstract] [Full Text] [Related]
2. Follicle-stimulating hormone induced epithelial-mesenchymal transition of epithelial ovarian cancer cells through follicle-stimulating hormone receptor PI3K/Akt-Snail signaling pathway.
Yang Y; Zhang J; Zhu Y; Zhang Z; Sun H; Feng Y
Int J Gynecol Cancer; 2014 Nov; 24(9):1564-74. PubMed ID: 25340291
[TBL] [Abstract][Full Text] [Related]
3. RNA demethylase ALKBH5 promotes ovarian carcinogenesis in a simulated tumour microenvironment through stimulating NF-κB pathway.
Jiang Y; Wan Y; Gong M; Zhou S; Qiu J; Cheng W
J Cell Mol Med; 2020 Jun; 24(11):6137-6148. PubMed ID: 32329191
[TBL] [Abstract][Full Text] [Related]
4. ALKBH5 activates FAK signaling through m6A demethylation in
Sun R; Yuan L; Jiang Y; Wan Y; Ma X; Yang J; Sun G; Zhou S; Wang H; Qiu J; Zhang L; Cheng W
Theranostics; 2023; 13(2):833-848. PubMed ID: 36632222
[No Abstract] [Full Text] [Related]
5. ALKBH5-mediated m
Hao L; Yin J; Yang H; Li C; Zhu L; Liu L; Zhong J
Aging (Albany NY); 2021 Jan; 13(3):4045-4062. PubMed ID: 33428593
[TBL] [Abstract][Full Text] [Related]
6. ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer.
Nie S; Zhang L; Liu J; Wan Y; Jiang Y; Yang J; Sun R; Ma X; Sun G; Meng H; Xu M; Cheng W
J Exp Clin Cancer Res; 2021 Sep; 40(1):284. PubMed ID: 34496932
[TBL] [Abstract][Full Text] [Related]
7. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.
Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R
Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928
[TBL] [Abstract][Full Text] [Related]
8. RNA demethylase ALKBH5 inhibits TGF-β-induced EMT by regulating TGF-β/SMAD signaling in non-small cell lung cancer.
Sun Z; Su Z; Zhou Z; Wang S; Wang Z; Tong X; Li C; Wang Y; Chen X; Lei Z; Zhang HT
FASEB J; 2022 May; 36(5):e22283. PubMed ID: 35344216
[TBL] [Abstract][Full Text] [Related]
9. ALKBH5 Inhibits Pancreatic Cancer Motility by Decreasing Long Non-Coding RNA KCNK15-AS1 Methylation.
He Y; Hu H; Wang Y; Yuan H; Lu Z; Wu P; Liu D; Tian L; Yin J; Jiang K; Miao Y
Cell Physiol Biochem; 2018; 48(2):838-846. PubMed ID: 30032148
[TBL] [Abstract][Full Text] [Related]
10. HPV E7-drived ALKBH5 promotes cervical cancer progression by modulating m6A modification of PAK5.
Huo FC; Zhu ZM; Du WQ; Pan YJ; Jiang X; Kang MJ; Liu BW; Mou J; Pei DS
Pharmacol Res; 2023 Sep; 195():106863. PubMed ID: 37480971
[TBL] [Abstract][Full Text] [Related]
11. OCT4 mediates FSH-induced epithelial-mesenchymal transition and invasion through the ERK1/2 signaling pathway in epithelial ovarian cancer.
Liu L; Zhang J; Fang C; Zhang Z; Feng Y; Xi X
Biochem Biophys Res Commun; 2015 Jun; 461(3):525-32. PubMed ID: 25911324
[TBL] [Abstract][Full Text] [Related]
12. ALKBH5 inhibited autophagy of epithelial ovarian cancer through miR-7 and BCL-2.
Zhu H; Gan X; Jiang X; Diao S; Wu H; Hu J
J Exp Clin Cancer Res; 2019 Apr; 38(1):163. PubMed ID: 30987661
[TBL] [Abstract][Full Text] [Related]
13. ALKBH5 regulates paclitaxel resistance in NSCLC via inhibiting CEMIP-mediated EMT.
Gao L; Qiao L; Li Y; Jia L; Cui W; Yang J; Wu C; Wang L
Toxicol Appl Pharmacol; 2024 Feb; 483():116807. PubMed ID: 38199493
[TBL] [Abstract][Full Text] [Related]
14. Suppression of m6A mRNA modification by DNA hypermethylated ALKBH5 aggravates the oncological behavior of KRAS mutation/LKB1 loss lung cancer.
Zhang D; Ning J; Okon I; Zheng X; Satyanarayana G; Song P; Xu S; Zou MH
Cell Death Dis; 2021 May; 12(6):518. PubMed ID: 34016959
[TBL] [Abstract][Full Text] [Related]
15. Post-translational modification of RNA m6A demethylase ALKBH5 regulates ROS-induced DNA damage response.
Yu F; Wei J; Cui X; Yu C; Ni W; Bungert J; Wu L; He C; Qian Z
Nucleic Acids Res; 2021 Jun; 49(10):5779-5797. PubMed ID: 34048572
[TBL] [Abstract][Full Text] [Related]
16. The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma.
Jin S; Li M; Chang H; Wang R; Zhang Z; Zhang J; He Y; Ma H
Mol Cancer; 2022 Apr; 21(1):97. PubMed ID: 35395767
[TBL] [Abstract][Full Text] [Related]
17. Progranulin expression induced by follicle-stimulating hormone in ovarian cancer cell lines depends on the histological subtype.
Perez-Juarez CE; Arechavaleta-Velasco F; Mendez C; Díaz-Cueto L
Med Oncol; 2020 May; 37(7):59. PubMed ID: 32474861
[TBL] [Abstract][Full Text] [Related]
18. Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification.
Hu Y; Gong C; Li Z; Liu J; Chen Y; Huang Y; Luo Q; Wang S; Hou Y; Yang S; Xiao Y
Mol Cancer; 2022 Feb; 21(1):34. PubMed ID: 35114989
[TBL] [Abstract][Full Text] [Related]
19. ALKBH5-Mediated m6A Demethylation of GLUT4 mRNA Promotes Glycolysis and Resistance to HER2-Targeted Therapy in Breast Cancer.
Liu H; Lyu H; Jiang G; Chen D; Ruan S; Liu S; Zhou L; Yang M; Zeng S; He Z; Wang H; Li H; Zheng G; Liu B
Cancer Res; 2022 Nov; 82(21):3974-3986. PubMed ID: 36069931
[TBL] [Abstract][Full Text] [Related]
20. RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A-YTHDF2-dependent manner.
Shen D; Lin J; Xie Y; Zhuang Z; Xu G; Peng S; Tang G; Bai L; Zhu M; Zhang Y; Huang Z; Wang P; Liu X; Huang M; Luo Y; Wang X; Yu H
Clin Transl Med; 2023 May; 13(5):e1279. PubMed ID: 37203239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]